Cognitive-Behavioral Therapy for Suicide Prevention (CBT-SP): Treatment Model, Feasibility, and Acceptability - 08/08/11
, Gregory Brown, Ph.D., David A. Brent, M.D., Karen Wells, Ph.D., Kim Poling, L.C.S.W., John Curry, Ph.D., Betsy D. Kennard, Psy.D., Ann Wagner, Ph.D., Mary F. Cwik, Ph.D., Anat Brunstein Klomek, Ph.D., Tina Goldstein, Ph.D., Benedetto Vitiello, M.D., Shannon Barnett, M.D., Stephanie Daniel, Ph.D., Jennifer Hughes, B.A.Disclosure: Drs. Wells and Curry receive speaking fees from the REACH Institute. Dr. Wagner held stock in Johnson & Johnson in an amount deemed by government-wide regulations not to create a conflict of interest, and has since divested. The other authors report no conflicts of interest.
Abstract |
Objective |
To describe the elements of a manual-based cognitive-behavioral therapy for suicide prevention (CBT-SP) and to report its feasibility in preventing the recurrence of suicidal behavior in adolescents who have recently attempted suicide.
Method |
The CBT-SP was developed using a risk reduction and relapse prevention approach and theoretically grounded in principles of cognitive-behavioral therapy, dialectical behavioral therapy, and targeted therapies for suicidal youths with depression. The CBT-SP consists of acute and continuation phases, each lasting about 12 sessions, and includes a chain analysis of the suicidal event, safety plan development, skill building, psychoeducation, family intervention, and relapse prevention.
Results |
The CBT-SP was administered to 110 recent suicide attempters with depression aged 13 to 19 years (mean 15.8 years, SD 1.6) across five academic sites. Twelve or more sessions were completed by 72.4% of the sample.
Conclusions |
A specific intervention for adolescents at high risk for repeated suicide attempts has been developed and manual based, and further testing of its efficacy seems feasible. J. Am. Acad. Child Adolesc. Psychiatry, 2009;48(10):1005–1013.
Le texte complet de cet article est disponible en PDF.Key Words : suicide, psychotherapy, depression
Plan
| This study was funded by the National Institute of Mental Health through cooperative agreement grants MH66750 (Duke University Medical Center), MH66769 (Johns Hopkins University), MH66762 (New York State Psychiatric Institute), MH66775 (University of Pittsburgh), and MH66778 (University of Texas Southwestern Medical Center). This article is the subject of an editorial by Dr. Garry Walter in this issue. Clinical trial registration information–Treatment of Adolescent Suicide Attempters (TASA). URL: clinicaltrials.gov. Unique identifier: NCT00080158. |
Vol 48 - N° 10
P. 1005-1013 - octobre 2009 Retour au numéro
Article précédent
- Depressive Symptoms and Clinical Status During the Treatment of Adolescent Suicide Attempters (TASA) Study
- Benedetto Vitiello, David A. Brent, Laurence L. Greenhill, Graham Emslie, Karen Wells, John T. Walkup, Barbara Stanley, Oscar Bukstein, Betsy D. Kennard, Scott Compton, Barbara Coffey, Mary F. Cwik, Kelly Posner, Ann Wagner, John S. March, Mark Riddle, Tina Goldstein, John Curry, Lisa Capasso, Taryn Mayes, Sa Shen, S. Sonia Gugga, J. Blake Turner, Shannon Barnett, Jamie Zelazny
- Widespread Cortical Thinning Is a Robust Anatomical Marker for Attention-Deficit/Hyperactivity Disorder
- Katherine L. Narr, Roger P. Woods, James Lin, John Kim, Owen R. Phillips, Melissa Del’Homme, Rochelle Caplan, Arthur W. Toga, James T. McCracken, Jennifer G. Levitt
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?